Hydrophilic amylose-based graft copolymers for controlled protein release

20Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Graft copolymerization of 2-hydroxyethylmethacrylate (HEMA) onto high-amylose starch using ceric ammonium nitrate (CAN) as an initiator was carried out in an aqueous solution. Our attention has been focused on efficient and well controlled grafted copolymerization methods in order to obtain a biocompatible copolymer for controlled-release of drugs and proteins. Here, we report on the synthesis and physico-chemical characterization as well as other experiments to test the enzymatic resistance and the capacity of fermentation by colonic bacteria of this product. It can be observed that this copolymer gives a good controlled-release of drugs (Theophylline and Procaine hydrochloride), as well as proteins (BSA). The in vitro experiments let us know that quantities lower than 10% of BSA are released at pH 1.5 (stomach), keeping the protein in the matrix to be released at higher pHs (intestine), where the matrix suffers anaerobic degradation. © 2008 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Alias, J., Silva, I., Goñi, I., & Gurruchaga, M. (2008). Hydrophilic amylose-based graft copolymers for controlled protein release. Carbohydrate Polymers, 74(1), 31–40. https://doi.org/10.1016/j.carbpol.2008.01.012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free